CHEMBL333994
CHEMBL333994 (FK-480) is a potent and orally active Cholecystokinin A receptor (CCK-A receptor) antagonist, with an IC50 of 0.67 nM. CHEMBL333994 selectively antagonizes peripheral CCK receptors. CHEMBL333994 increases CCK mRNA level. CHEMBL333994 can be used for research of chronic pancreatitis[1][2][3].
Product Specifications
CAS Number
167820-10-2
Product Name Alternative
FK-480
UNSPSC
12352005
Target
Cholecystokinin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/1H-Indole-2-carboxamide,_N--_3R_-1-_2-fluorophenyl_-3,4,6,7-tetrahydro-4-oxopyrrolo-3,2,1-jk--1,4-benzodiazepin-3-yl--.html
Solubility
10 mM in DMSO
Smiles
O=C(C(N1)=CC2=C1C=CC=C2)N[C@H]3C(N4C5=C(CC4)C=CC=C5C(C6=CC=CC=C6F)=N3)=O
Molecular Formula
C26H19FN4O2
Molecular Weight
438.45
References & Citations
[1]Satoh Y, et al. Studies on a novel, potent and orally effective cholecystokinin A antagonist, FK-480. Synthesis and structure-activity relationships of FK-480 and related compounds. Chem Pharm Bull (Tokyo) . 1994 Oct;42 (10) :2071-83.|[2]Funakoshi A, et al. Effect of a new cholecystokinin antagonist (FK 480) on gene expression of cholecystokinin and secretin in rat intestine. J Gastroenterol. 1994 Jun;29 (3) :385-7. |[3]Moriyoshi Y, et al. Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally. J Gastroenterol. 1996 Apr;31 (2) :249-53
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CCKAR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
